Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Rolston, RK; Kant, JA
   t(15;17) reverse transcription-polymerase chain reaction with alternative splicing
   JOURNAL OF MOLECULAR DIAGNOSTICS
   
   R.K. Rolston e J.A. Kant, "t(15;17) reverse transcription-polymerase chain reaction with alternative splicing", J MOL DIAGN, 3(3), 2001, pp. 123-125
2. Grimwade, D
   The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia
   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
   
   D. Grimwade, "The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia", BEST P R C, 14(3), 2001, pp. 497-529
3. Dash, A; Gilliland, DG
   Molecular genetics of acute myeloid leukaemia
   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
   
   A. Dash e D.G. Gilliland, "Molecular genetics of acute myeloid leukaemia", BEST P R C, 14(1), 2001, pp. 49-64
4. Graessle, S; Loidl, P; Brosch, G
   Histone acetylation: plants and fungi as model systems for the investigation of histone deacetylases
   CELLULAR AND MOLECULAR LIFE SCIENCES
   
   S. Graessle et al., "Histone acetylation: plants and fungi as model systems for the investigation of histone deacetylases", CELL MOL L, 58(5-6), 2001, pp. 704-720
5. Merghoub, T; Gurrieri, C; Piazza, F; Pandolfi, PP
   Modeling acute promyelocytic leukemia in the mouse: New insights in the pathogenesis of human leukemias
   BLOOD CELLS MOLECULES AND DISEASES
   
   T. Merghoub et al., "Modeling acute promyelocytic leukemia in the mouse: New insights in the pathogenesis of human leukemias", BL CELL M D, 27(1), 2001, pp. 231-248
6. Pollock, JL; Westervelt, P; Walter, MJ; Lane, AA; Ley, TJ
   Mouse models of acute promyelocytic leukemia
   CURRENT OPINION IN HEMATOLOGY
   
   J.L. Pollock et al., "Mouse models of acute promyelocytic leukemia", CURR OPIN H, 8(4), 2001, pp. 206-211
7. Kohno, A; Tsuzuki, S; Kasai, M; Miyamura, K; Emi, N; Tanimoto, M; Saito, H
   Acute promyelocytic leukemia with apparently normal karyotype: Molecular findings and response to all-trans retinoic acid
   LEUKEMIA & LYMPHOMA
   
   A. Kohno et al., "Acute promyelocytic leukemia with apparently normal karyotype: Molecular findings and response to all-trans retinoic acid", LEUK LYMPH, 42(1-2), 2001, pp. 151-161
8. Mathews, V; Chandy, M; Srivastava, A
   Arsenic trioxide in the management of acute promyelocytic leukaemia
   NATIONAL MEDICAL JOURNAL OF INDIA
   
   V. Mathews et al., "Arsenic trioxide in the management of acute promyelocytic leukaemia", NAT MED J I, 14(4), 2001, pp. 215-222
9. Pandolfi, PP
   Oncogenes and tumor suppressors in the molecular pathogenesis of acute promyelocytic leukemia
   HUMAN MOLECULAR GENETICS
   
   P.P. Pandolfi, "Oncogenes and tumor suppressors in the molecular pathogenesis of acute promyelocytic leukemia", HUM MOL GEN, 10(7), 2001, pp. 769-775
10. Wu, XM; Pandolfi, PP
    Mouse models for multistep tumorigenesis
    TRENDS IN CELL BIOLOGY
    
    X.M. Wu e P.P. Pandolfi, "Mouse models for multistep tumorigenesis", TR CELL BIO, 11(11), 2001, pp. S2-S9
11. Hann, B; Balmain, A
    Building 'validated' mouse models of human cancer
    CURRENT OPINION IN CELL BIOLOGY
    
    B. Hann e A. Balmain, "Building 'validated' mouse models of human cancer", CURR OP CEL, 13(6), 2001, pp. 778-784
12. de The, H; Chelbi-Alix, MK
    APL, a model disease for cancer therapies?
    ONCOGENE
    
    H. de The e M.K. Chelbi-Alix, "APL, a model disease for cancer therapies?", ONCOGENE, 20(49), 2001, pp. 7136-7139
13. Zhang, TD; Chen, GQ; Wang, ZG; Wang, ZY; Chen, SJ; Chen, Z
    Arsenic trioxide, a therapeutic agent for APL
    ONCOGENE
    
    T.D. Zhang et al., "Arsenic trioxide, a therapeutic agent for APL", ONCOGENE, 20(49), 2001, pp. 7146-7153
14. Cassinat, B; Chomienne, C
    Biological features of primary APL blasts: their relevance to the understanding of granulopoiesis, leukemogenesis and patient management
    ONCOGENE
    
    B. Cassinat e C. Chomienne, "Biological features of primary APL blasts: their relevance to the understanding of granulopoiesis, leukemogenesis and patient management", ONCOGENE, 20(49), 2001, pp. 7154-7160
15. Benoit, G; Roussel, M; Pendino, F; Segal-Bendirdjian, E; Lanotte, M
    Orchestration of multiple arrays of signal cross-talk and combinatorial interactions for maturation and cell death: another vision of t(15;17) preleukemic blast and APL-cell maturation
    ONCOGENE
    
    G. Benoit et al., "Orchestration of multiple arrays of signal cross-talk and combinatorial interactions for maturation and cell death: another vision of t(15;17) preleukemic blast and APL-cell maturation", ONCOGENE, 20(49), 2001, pp. 7161-7177
16. Lin, RJ; Sternsdorf, T; Tini, M; Evans, RM
    Transcriptional regulation in acute promyelocytic leukemia
    ONCOGENE
    
    R.J. Lin et al., "Transcriptional regulation in acute promyelocytic leukemia", ONCOGENE, 20(49), 2001, pp. 7204-7215
17. Piazza, F; Gurrieri, C; Pandolfi, PP
    The theory of APL
    ONCOGENE
    
    F. Piazza et al., "The theory of APL", ONCOGENE, 20(49), 2001, pp. 7216-7222
18. Zhu, J; Lallemand-Breitenbach, V; de The, H
    Pathways of retinoic acid- or arsenic trioxide-induced PML/RAR alpha catabolism, role of oncogene degradation in disease remission
    ONCOGENE
    
    J. Zhu et al., "Pathways of retinoic acid- or arsenic trioxide-induced PML/RAR alpha catabolism, role of oncogene degradation in disease remission", ONCOGENE, 20(49), 2001, pp. 7257-7265
19. Roussel, MJS; Lanotte, M
    Maturation sensitive and resistant t(15;17) NB4 cell lines as tools for APL physiopathology: nomenclature of cells and repertory of their known genetic alterations and phenotypes
    ONCOGENE
    
    M.J.S. Roussel e M. Lanotte, "Maturation sensitive and resistant t(15;17) NB4 cell lines as tools for APL physiopathology: nomenclature of cells and repertory of their known genetic alterations and phenotypes", ONCOGENE, 20(49), 2001, pp. 7287-7291
20. Pandolfi, PP
    In vivo analysis of the molecular genetics of acute promyelocytic leukemia
    ONCOGENE
    
    P.P. Pandolfi, "In vivo analysis of the molecular genetics of acute promyelocytic leukemia", ONCOGENE, 20(40), 2001, pp. 5726-5735
21. Kosugi, H; Ito, M; Yamamoto, Y; Towatari, M; Ito, M; Ueda, R; Saito, H; Naoe, T
    In vivo effects of a histone deacetylase inhibitor, FK228, on human acute promyelocytic leukemia in NOD/Shi-scid/scid mice
    JAPANESE JOURNAL OF CANCER RESEARCH
    
    H. Kosugi et al., "In vivo effects of a histone deacetylase inhibitor, FK228, on human acute promyelocytic leukemia in NOD/Shi-scid/scid mice", JPN J CANC, 92(5), 2001, pp. 529-536
22. Benoit, GR; Flexor, M; Besancon, F; Altucci, L; Rossin, A; Hillion, J; Balajthy, Z; Legres, L; Segal-Bendirdjian, E; Gronemeyer, H; Lanotte, M
    Autonomous rexinoid death signaling is suppressed by converging signaling pathways in immature leukemia cells
    MOLECULAR ENDOCRINOLOGY
    
    G.R. Benoit et al., "Autonomous rexinoid death signaling is suppressed by converging signaling pathways in immature leukemia cells", MOL ENDOCR, 15(7), 2001, pp. 1154-1169
23. Muto, A; Kizaki, M; Kawamura, C; Matsushita, H; Fukuchi, Y; Umezawa, A; Yamada, T; Hata, J; Hozumi, N; Yamato, K; Ito, M; Ueyama, Y; Ikeda, Y
    A novel differentiation-inducing therapy for acute promyelocytic leukemia with a combination of arsenic trioxide and GM-CSF
    LEUKEMIA
    
    A. Muto et al., "A novel differentiation-inducing therapy for acute promyelocytic leukemia with a combination of arsenic trioxide and GM-CSF", LEUKEMIA, 15(8), 2001, pp. 1176-1184
24. Tobal, K; Moore, H; Macheta, M; Yin, JAL
    Monitoring minimal residual disease and predicting relapse in APL by quantitating PML-RAR alpha transcripts with a sensitive competitive RT-PCR method
    LEUKEMIA
    
    K. Tobal et al., "Monitoring minimal residual disease and predicting relapse in APL by quantitating PML-RAR alpha transcripts with a sensitive competitive RT-PCR method", LEUKEMIA, 15(7), 2001, pp. 1060-1065
25. Lallemand-Breitenbach, V; Zhu, J; de The, H
    Promyelocytic leukemia, a unique model to design treatments targeting oncogenes
    M S-MEDECINE SCIENCES
    
    V. Lallemand-Breitenbach et al., "Promyelocytic leukemia, a unique model to design treatments targeting oncogenes", M S-MED SCI, 17(1), 2001, pp. 14-22
26. Soignet, SL; Frankel, SR; Douer, D; Tallman, MS; Kantarjian, H; Calleja, E; Stone, RM; Kalaycio, M; Scheinberg, DA; Steinherz, P; Sievers, EL; Coutre, S; Dahlberg, S; Ellison, R; Warrell, RP
    United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia
    JOURNAL OF CLINICAL ONCOLOGY
    
    S.L. Soignet et al., "United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia", J CL ONCOL, 19(18), 2001, pp. 3852-3860
27. Ozpolat, B; Lopez-Berestein, G; Mehta, K
    ATRA(ouble) in the treatment of acute promyelocytic leukemia
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
    
    B. Ozpolat et al., "ATRA(ouble) in the treatment of acute promyelocytic leukemia", J BIOL REG, 15(2), 2001, pp. 107-122
28. Chillon, MC; Garcia-Sanz, R; Balanzategui, A; Ramos, F; Fernandez-Calvo, J; Rodriguez, MJ; Rodriguez-Salazar, MI; Corrales, A; Calmuntia, MJ; Orfao, A; Gonzalez, M; San Miguel, JF
    Molecular characterization of acute myeloblastic leukemia according to thenew WHO classification: a different distribution in Central-West Spain
    HAEMATOLOGICA
    
    M.C. Chillon et al., "Molecular characterization of acute myeloblastic leukemia according to thenew WHO classification: a different distribution in Central-West Spain", HAEMATOLOG, 86(2), 2001, pp. 162-166
29. Foley, R; Soamboonsrup, P; Carter, RF; Benger, A; Meyer, R; Walker, I; Wan, Y; Patterson, W; Orzel, A; Sunisloe, L; Leber, B; Neame, PB
    CD34-positive acute promyelocytic leukemia is associated with leukocytosis, microgranular/hypogranular morphology, expression of CD2 and bcr3 isoform
    AMERICAN JOURNAL OF HEMATOLOGY
    
    R. Foley et al., "CD34-positive acute promyelocytic leukemia is associated with leukocytosis, microgranular/hypogranular morphology, expression of CD2 and bcr3 isoform", AM J HEMAT, 67(1), 2001, pp. 34-41
30. Asou, N; Adachi, K; Tamura, J; Kanamaru, A; Kageyama, S; Hiraoka, A; Omoto, E; Akiyama, H; Tsubaki, K; Saito, K; Kuriyama, K; Oh, H; Kitano, K; Miyawaki, S; Takeyama, K; Yamada, O; Nishikawa, K; Takahashi, M; Matsuda, S; Ohtake, S; Ohno, R
    Analysis of prognostic factors in newly diagnosed patients with acute promyelocytic leukemia: the APL92 study of the Japan Adult Leukemia Study Group(JALSG)
    CANCER CHEMOTHERAPY AND PHARMACOLOGY
    
    N. Asou et al., "Analysis of prognostic factors in newly diagnosed patients with acute promyelocytic leukemia: the APL92 study of the Japan Adult Leukemia Study Group(JALSG)", CANC CHEMOT, 48, 2001, pp. S65-S71
31. Takayama, N; Kizaki, M; Hida, T; Kinjo, K; Ikeda, Y
    Novel mutation in the PML/RAR alpha chimeric gene exhibits dramatically decreased ligand-binding activity and confers acquired resistance to retinoicacid in acute promyelocytic leukemia
    EXPERIMENTAL HEMATOLOGY
    
    N. Takayama et al., "Novel mutation in the PML/RAR alpha chimeric gene exhibits dramatically decreased ligand-binding activity and confers acquired resistance to retinoicacid in acute promyelocytic leukemia", EXP HEMATOL, 29(7), 2001, pp. 864-872
32. Seeler, JS; Marchio, A; Losson, R; Desterro, JMP; Hay, RT; Chambon, P; Dejean, A
    Common properties of nuclear body protein SP100 and TIF1 alpha chromatin factor: Role of SUMO modification
    MOLECULAR AND CELLULAR BIOLOGY
    
    J.S. Seeler et al., "Common properties of nuclear body protein SP100 and TIF1 alpha chromatin factor: Role of SUMO modification", MOL CELL B, 21(10), 2001, pp. 3314-3324
33. Tallman, MS
    Arsenic trioxide: its role in acute promyelocytic leukemia and potential in other hematologic malignancies
    BLOOD REVIEWS
    
    M.S. Tallman, "Arsenic trioxide: its role in acute promyelocytic leukemia and potential in other hematologic malignancies", BLOOD REV, 15(3), 2001, pp. 133-142
34. Nabhan, C; Mehta, J; Tallman, MS
    The role of bone marrow transplantation in acute promyelocytic leukemia
    BONE MARROW TRANSPLANTATION
    
    C. Nabhan et al., "The role of bone marrow transplantation in acute promyelocytic leukemia", BONE MAR TR, 28(3), 2001, pp. 219-226
35. Suzuki, H; Imaizumi, M; Sato, A; Yoshinari, M; Rikiishi, T; Endo, M; Takano, T; Shimizu, T; Hatae, Y; Fujimoto, T; Hayashi, Y; Iinuma, K
    Monitoring of minimal residual disease in children with acute promyelocytic leukemia by RT-PCR detecting PML/RAR alpha chimeric gene: A retrospectivestudy of clinical feasibility
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
    
    H. Suzuki et al., "Monitoring of minimal residual disease in children with acute promyelocytic leukemia by RT-PCR detecting PML/RAR alpha chimeric gene: A retrospectivestudy of clinical feasibility", TOH J EX ME, 193(2), 2001, pp. 127-139
36. Faretta, M; Di Croce, L; Pelicci, PG
    Effects of the acute myeloid leukemia-associated fusion proteins on nuclear architecture
    SEMINARS IN HEMATOLOGY
    
    M. Faretta et al., "Effects of the acute myeloid leukemia-associated fusion proteins on nuclear architecture", SEM HEMATOL, 38(1), 2001, pp. 42-53
37. Rego, EM; Pandolfi, PP
    Analysis of the molecular genetics of acute promyelocytic leukemia in mouse models
    SEMINARS IN HEMATOLOGY
    
    E.M. Rego e P.P. Pandolfi, "Analysis of the molecular genetics of acute promyelocytic leukemia in mouse models", SEM HEMATOL, 38(1), 2001, pp. 54-70
38. Liao, C; Wang, XY; Wei, HQ; Li, SQ; Merghoub, T; Pandolfi, PP; Wolgemuth, DJ
    Altered myelopoiesis and the development of acute myeloid leukemia in transgenic mice overexpressing cyclin A1
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    C. Liao et al., "Altered myelopoiesis and the development of acute myeloid leukemia in transgenic mice overexpressing cyclin A1", P NAS US, 98(12), 2001, pp. 6853-6858
39. Adamson, AL; Kenney, S
    Epstein-Barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies
    JOURNAL OF VIROLOGY
    
    A.L. Adamson e S. Kenney, "Epstein-Barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies", J VIROLOGY, 75(5), 2001, pp. 2388-2399
40. Kogan, SC; Brown, DE; Shultz, DB; Truong, BTH; Lallemand-Breitenbach, V; Guillemin, MC; Lagasse, E; Weissman, IL; Bishop, JM
    BCL-2 cooperates with promyelocytic leukemia retinoic acid receptor alpha chimeric protein (PMLRAR alpha) to block neutrophil differentiation and initiate acute leukemia
    JOURNAL OF EXPERIMENTAL MEDICINE
    
    S.C. Kogan et al., "BCL-2 cooperates with promyelocytic leukemia retinoic acid receptor alpha chimeric protein (PMLRAR alpha) to block neutrophil differentiation and initiate acute leukemia", J EXP MED, 193(4), 2001, pp. 531-543
41. Largaespada, DA
    Haploinsufficiency for tumor suppression: The hazards of being single and living a long time
    JOURNAL OF EXPERIMENTAL MEDICINE
    
    D.A. Largaespada, "Haploinsufficiency for tumor suppression: The hazards of being single and living a long time", J EXP MED, 193(4), 2001, pp. F15-F18
42. He, LZ; Tolentino, T; Grayson, P; Zhong, S; Warrell, RP; Rifkind, RA; Marks, PA; Richon, VM; Pandolfi, PP
    Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia
    JOURNAL OF CLINICAL INVESTIGATION
    
    L.Z. He et al., "Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia", J CLIN INV, 108(9), 2001, pp. 1321-1330
43. Murges, D; Quadt, I; Schroer, J; Knebel-Morsdorf, D
    Dynamic nuclear localization of the baculovirus proteins IE2 and PE38 during the infection cycle: The promyelocytic leukemia protein colocalizes withIE2
    EXPERIMENTAL CELL RESEARCH
    
    D. Murges et al., "Dynamic nuclear localization of the baculovirus proteins IE2 and PE38 during the infection cycle: The promyelocytic leukemia protein colocalizes withIE2", EXP CELL RE, 264(2), 2001, pp. 219-232
44. Idres, N; Benoit, G; Flexor, MA; Lanotte, M; Chabot, GG
    Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites
    CANCER RESEARCH
    
    N. Idres et al., "Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites", CANCER RES, 61(2), 2001, pp. 700-705
45. Mologni, L; Marchesi, E; Nielsen, PE; Gambacorti-Passerini, C
    Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid
    CANCER RESEARCH
    
    L. Mologni et al., "Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid", CANCER RES, 61(14), 2001, pp. 5468-5473
46. Ferrara, FF; Fazi, F; Bianchini, A; Padula, F; Gelmetti, V; Minucci, S; Mancini, M; Pelicci, PG; Lo Coco, F; Nervi, C
    Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia
    CANCER RESEARCH
    
    F.F. Ferrara et al., "Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia", CANCER RES, 61(1), 2001, pp. 2-7
47. Petti, MC; Pinazzi, MB; Diverio, D; Romano, A; Petrucci, MT; De Santis, S; Meloni, G; Tafuri, A; Mandelli, F; Lo Coco, F
    Prolonged molecular remission in advanced acute promyelocytic leukaemia after treatment with gemtuzumab ozogamicin (Mylotarg (TM) CMA-676)
    BRITISH JOURNAL OF HAEMATOLOGY
    
    M.C. Petti et al., "Prolonged molecular remission in advanced acute promyelocytic leukaemia after treatment with gemtuzumab ozogamicin (Mylotarg (TM) CMA-676)", BR J HAEM, 115(1), 2001, pp. 63-65
48. Virchis, A; Massey, E; Butler, T; Devaraj, P; Wright, F; Secker-Walker, L; Prentice, HG; Mehta, A
    Acute myeloblastic leukaemias of FAB types M6 and M4, with cryptic PML/RARalpha fusion gene formation, relapsing as acute promyelocytic leukaemia M3
    BRITISH JOURNAL OF HAEMATOLOGY
    
    A. Virchis et al., "Acute myeloblastic leukaemias of FAB types M6 and M4, with cryptic PML/RARalpha fusion gene formation, relapsing as acute promyelocytic leukaemia M3", BR J HAEM, 114(3), 2001, pp. 551-556
49. Gonzalez, M; Barragan, E; Bolufer, P; Chillon, C; Colomer, D; Borstein, R; Calasanz, MJ; Gomez-Casares, MT; Villegas, A; Marugan, I; Roman, J; Martin, G; Rayon, C; Deben, G; Tormo, M; Diaz-Mediavilla, J; Esteve, J; Gonzalez-San Miguel, J; Rivas, C; Perez-Equiza, K; Garcia-Sanz, R; Capote, FJ; Ribera, JM; Arias, J; Leon, A; Sanz, MA
    Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML-RAR alpha isoforms: a study of the PETHEMA group
    BRITISH JOURNAL OF HAEMATOLOGY
    
    M. Gonzalez et al., "Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML-RAR alpha isoforms: a study of the PETHEMA group", BR J HAEM, 114(1), 2001, pp. 99-103
50. Jurcic, JG; Nimer, SD; Scheinberg, DA; DeBlasio, T; Warrell, RP; Miller, WH
    Prognostic significance of minimal residual disease detection and PML/RAR-alpha isoform type: long-term follow-up in acute promyelocytic leukemia
    BLOOD
    
    J.G. Jurcic et al., "Prognostic significance of minimal residual disease detection and PML/RAR-alpha isoform type: long-term follow-up in acute promyelocytic leukemia", BLOOD, 98(9), 2001, pp. 2651-2656
51. Kini, AR; Peterson, LC; Tallman, MS; Lingen, MW
    Angiogenesis in acute promyelocytic leukemia: induction by vascular endothelial growth factor and inhibition by all-trans retinoic acid
    BLOOD
    
    A.R. Kini et al., "Angiogenesis in acute promyelocytic leukemia: induction by vascular endothelial growth factor and inhibition by all-trans retinoic acid", BLOOD, 97(12), 2001, pp. 3919-3924
52. Gianni', M; Kalac, Y; Ponzanelli, I; Rambaldi, A; Terao, M; Garattini, E
    Tyrosine kinase inhibitor ST1571 potentiates the pharmacologic activity ofretinoic acid in acute promyelocytic leukemia cells: effects on the degradation of RAR alpha and PML-RAR alpha
    BLOOD
    
    M. Gianni' et al., "Tyrosine kinase inhibitor ST1571 potentiates the pharmacologic activity ofretinoic acid in acute promyelocytic leukemia cells: effects on the degradation of RAR alpha and PML-RAR alpha", BLOOD, 97(10), 2001, pp. 3234-3243
53. Douer, D
    Transcription therapy for acute promyelocytic leukaemia
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    D. Douer, "Transcription therapy for acute promyelocytic leukaemia", EXPERT OP I, 9(2), 2000, pp. 329-346
54. He, LZ; Bhaumik, M; Tribioli, C; Rego, EM; Ivins, S; Zelent, A; Pandolfi, PP
    Two critical hits for promyelocytic leukemia
    MOLECULAR CELL
    
    L.Z. He et al., "Two critical hits for promyelocytic leukemia", MOL CELL, 6(5), 2000, pp. 1131-1141
55. Parrado, A; Chomienne, C; Padua, RA
    Retinoic acid receptor alpha (RAR alpha) mutations in human leukemia
    LEUKEMIA & LYMPHOMA
    
    A. Parrado et al., "Retinoic acid receptor alpha (RAR alpha) mutations in human leukemia", LEUK LYMPH, 39(3-4), 2000, pp. 271-282
56. Sumimoto, Y; Maeda, Y; Naiki, Y; Sono, H; Miyatake, J; Sakaguchi, M; Matsuda, M; Kanamaru, A
    Establishment of a myeloid cell line, YM711, characterized by retinoid resistance
    LEUKEMIA & LYMPHOMA
    
    Y. Sumimoto et al., "Establishment of a myeloid cell line, YM711, characterized by retinoid resistance", LEUK LYMPH, 39(3-4), 2000, pp. 373
57. Huang, SY; Yang, CH; Chen, YC
    Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: an useful salvage therapy
    LEUKEMIA & LYMPHOMA
    
    S.Y. Huang et al., "Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: an useful salvage therapy", LEUK LYMPH, 38(3-4), 2000, pp. 283
58. Laczika, K; Mitterbauer, G; Weltermann, A; Knobl, P; Thalhammer-Scherrer, R; Haas, OA; Lechner, K; Jaeger, U
    Prolonged third remission in a patient with acute promyelocytic leukemia after consolidation chemotherapy with intermittent intermediate dose Ara-C and maintenance with intermittent all-trans retinoic acid (ATRA)
    LEUKEMIA & LYMPHOMA
    
    K. Laczika et al., "Prolonged third remission in a patient with acute promyelocytic leukemia after consolidation chemotherapy with intermittent intermediate dose Ara-C and maintenance with intermittent all-trans retinoic acid (ATRA)", LEUK LYMPH, 36(5-6), 2000, pp. 625-629
59. Faderl, S; Kantarjian, HM; Talpaz, M; Estrov, Z
    Clinical significance of minimal residual disease in leukemia (Review)
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    S. Faderl et al., "Clinical significance of minimal residual disease in leukemia (Review)", INT J ONCOL, 17(6), 2000, pp. 1277-1287
60. Dhordain, P; Albagli, O; Honore, N; Guidez, F; Lantoine, D; Schmid, M; De The, H; Zelent, A; Koken, MHM
    Colocalization and heteromerization between the two human oncogene POZ/zinc finger proteins, LAZ3 (BCL6) and PLZF
    ONCOGENE
    
    P. Dhordain et al., "Colocalization and heteromerization between the two human oncogene POZ/zinc finger proteins, LAZ3 (BCL6) and PLZF", ONCOGENE, 19(54), 2000, pp. 6240-6250
61. Slack, JL; Rusiniak, ME
    Current issues in the management of acute promyelocytic leukemia
    ANNALS OF HEMATOLOGY
    
    J.L. Slack e M.E. Rusiniak, "Current issues in the management of acute promyelocytic leukemia", ANN HEMATOL, 79(5), 2000, pp. 227-238
62. Vickers, M; Jackson, G; Taylor, P
    The incidence of acute promyelocytic leukemia appears constant over most of a human lifespan, implying only one rate limiting mutation
    LEUKEMIA
    
    M. Vickers et al., "The incidence of acute promyelocytic leukemia appears constant over most of a human lifespan, implying only one rate limiting mutation", LEUKEMIA, 14(4), 2000, pp. 722-726
63. Kinjo, K; Kizaki, M; Muto, A; Fukuchi, Y; Umezawa, A; Yamato, K; Nishihara, T; Hata, J; Ito, M; Ueyama, Y; Ikeda, Y
    Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoicacid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice
    LEUKEMIA
    
    K. Kinjo et al., "Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoicacid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice", LEUKEMIA, 14(3), 2000, pp. 431-438
64. Waxman, S
    Differentiation therapy in acute myelogenous leukemia (non-APL)
    LEUKEMIA
    
    S. Waxman, "Differentiation therapy in acute myelogenous leukemia (non-APL)", LEUKEMIA, 14(3), 2000, pp. 491-496
65. Cassinat, B; Zassadowski, F; Balitrand, N; Barbey, C; Rain, JD; Fenaux, P; Degos, L; Vidaud, M; Chomienne, C
    Quantitation of minimal residual disease in acute promyelocytic leukemia patients with t(15;17) translocation using real-time RT-PCR
    LEUKEMIA
    
    B. Cassinat et al., "Quantitation of minimal residual disease in acute promyelocytic leukemia patients with t(15;17) translocation using real-time RT-PCR", LEUKEMIA, 14(2), 2000, pp. 324-328
66. Grolleau, A; Wietzerbin, J; Beretta, L
    Defect in the regulation of 4E-BP1 and 2, two repressors of translation initiation, in the retinoid acid resistant cell lines, NB4-R1 and NE4-R2
    LEUKEMIA
    
    A. Grolleau et al., "Defect in the regulation of 4E-BP1 and 2, two repressors of translation initiation, in the retinoid acid resistant cell lines, NB4-R1 and NE4-R2", LEUKEMIA, 14(11), 2000, pp. 1909-1914
67. Kitamura, K; Minami, Y; Yamamoto, K; Akao, Y; Kiyoi, H; Saito, H; Naoe, T
    Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis
    LEUKEMIA
    
    K. Kitamura et al., "Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis", LEUKEMIA, 14(10), 2000, pp. 1743-1750
68. Gordon, JA; Pockwinse, SM; Stewart, FM; Quesenberry, PJ; Nakamura, T; Croce, CM; Lian, JB; Stein, JL; van Wijnen, AJ; Stein, GS
    Modified intranuclear organization of regulatory factors in human acute leukemias: Reversal after treatment
    JOURNAL OF CELLULAR BIOCHEMISTRY
    
    J.A. Gordon et al., "Modified intranuclear organization of regulatory factors in human acute leukemias: Reversal after treatment", J CELL BIOC, 77(1), 2000, pp. 30-43
69. Meyers, S; Hiebert, SW
    Alterations in subnuclear trafficking of nuclear regulatory factors in acute leukemia
    JOURNAL OF CELLULAR BIOCHEMISTRY
    
    S. Meyers e S.W. Hiebert, "Alterations in subnuclear trafficking of nuclear regulatory factors in acute leukemia", J CELL BIOC, 2000, pp. 93-98
70. Ma, ESK; Au, WY; Wan, TSK; Kwong, YL; Chan, LC
    Translocation (15;17)(q22;q21) not associated with acute promyelocytic leukemia and negative for PML/RAR alpha rearrangement
    HAEMATOLOGICA
    
    E.S.K. Ma et al., "Translocation (15;17)(q22;q21) not associated with acute promyelocytic leukemia and negative for PML/RAR alpha rearrangement", HAEMATOLOG, 85(7), 2000, pp. 768-769
71. Breems-de Ridder, MC; Lowenberg, B; Jansen, JH
    Retinoic acid receptor fusion proteins: friend or foe
    MOLECULAR AND CELLULAR ENDOCRINOLOGY
    
    M.C. Breems-de Ridder et al., "Retinoic acid receptor fusion proteins: friend or foe", MOL C ENDOC, 165(1-2), 2000, pp. 1-6
72. Mattson, JC
    Acute promyelocytic leukemia - From morphology to molecular lesions
    CLINICS IN LABORATORY MEDICINE
    
    J.C. Mattson, "Acute promyelocytic leukemia - From morphology to molecular lesions", CLIN LAB M, 20(1), 2000, pp. 83
73. Weil, SC
    Minimal residual disease in acute promyelocytic leukemia
    CLINICS IN LABORATORY MEDICINE
    
    S.C. Weil, "Minimal residual disease in acute promyelocytic leukemia", CLIN LAB M, 20(1), 2000, pp. 105
74. Bartolo, C; Viswanatha, DS
    Molecular diagnosis in pediatric acute leukemias
    CLINICS IN LABORATORY MEDICINE
    
    C. Bartolo e D.S. Viswanatha, "Molecular diagnosis in pediatric acute leukemias", CLIN LAB M, 20(1), 2000, pp. 139
75. Yamanaka, S; Zhang, XY; Maeda, M; Miura, K; Wang, S; Farese, RV; Iwao, H; Innerarity, TL
    Essential role of NAT1/p97/DAP5 in embryonic differentiation and the retinoic acid pathway
    EMBO JOURNAL
    
    S. Yamanaka et al., "Essential role of NAT1/p97/DAP5 in embryonic differentiation and the retinoic acid pathway", EMBO J, 19(20), 2000, pp. 5533-5541
76. Zhang, JW; Gu, J; Wang, ZY; Chen, SJ; Chen, Z
    Mechanisms of all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells
    JOURNAL OF BIOSCIENCES
    
    J.W. Zhang et al., "Mechanisms of all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells", J BIOSCI, 25(3), 2000, pp. 275-284
77. Hansen, LA; Sigman, CC; Andreola, F; Ross, SA; Kelloff, GJ; De Luca, LM
    Retinoids in chemoprevention and differentiation therapy
    CARCINOGENESIS
    
    L.A. Hansen et al., "Retinoids in chemoprevention and differentiation therapy", CARCINOGENE, 21(7), 2000, pp. 1271-1279
78. Stewart, AK; Schuh, AC
    White cells 2: impact of understanding the molecular basis of haematological malignant disorders on clinical practice
    LANCET
    
    A.K. Stewart e A.C. Schuh, "White cells 2: impact of understanding the molecular basis of haematological malignant disorders on clinical practice", LANCET, 355(9213), 2000, pp. 1447-1453
79. Zimonjic, DB; Pollock, JL; Westervelt, P; Popescu, NC; Ley, TJ
    Acquired, nonrandom chromosomal abnormalities associated with the development of acute promyelocytic leukemia in transgenic mice
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    D.B. Zimonjic et al., "Acquired, nonrandom chromosomal abnormalities associated with the development of acute promyelocytic leukemia in transgenic mice", P NAS US, 97(24), 2000, pp. 13306-13311
80. Rego, EM; He, LZ; Warrell, RP; Wang, ZG; Pandolfi, PP
    Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RAR alpha and PLZF-RAR alpha oncoproteins
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    E.M. Rego et al., "Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RAR alpha and PLZF-RAR alpha oncoproteins", P NAS US, 97(18), 2000, pp. 10173-10178
81. Bolufer, P; Barragan, E; Sanz, MA; Martin, G; Lerma, E; de Ribera, EA
    Monitoring of minimal residual disease by combined detection of PML/RAR alpha and RAR alpha/PML rearrangements in acute promyelocytic leukemia
    MEDICINA CLINICA
    
    P. Bolufer et al., "Monitoring of minimal residual disease by combined detection of PML/RAR alpha and RAR alpha/PML rearrangements in acute promyelocytic leukemia", MED CLIN, 114(8), 2000, pp. 281-285
82. Rusiniak, ME; Yu, M; Ross, DT; Tolhurst, EC; Slack, JL
    Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia
    CANCER RESEARCH
    
    M.E. Rusiniak et al., "Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia", CANCER RES, 60(7), 2000, pp. 1824-1829
83. Kitamura, K; Hoshi, S; Koike, M; Kiyoi, H; Saito, H; Naoe, T
    Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-transretinoic acid
    BRITISH JOURNAL OF HAEMATOLOGY
    
    K. Kitamura et al., "Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-transretinoic acid", BR J HAEM, 108(4), 2000, pp. 696-702
84. Cote, S; Zhou, DC; Bianchini, A; Nervi, C; Gallagher, RE; Miller, WH
    Altered ligand binding and transcriptional regulation by mutations in the PML/RAR alpha ligand-binding domain arising in retinoic acid-resistant patients with acute promyelocytic leukemia
    BLOOD
    
    S. Cote et al., "Altered ligand binding and transcriptional regulation by mutations in the PML/RAR alpha ligand-binding domain arising in retinoic acid-resistant patients with acute promyelocytic leukemia", BLOOD, 96(9), 2000, pp. 3200-3208
85. Shao, WL; Rosenauer, A; Mann, K; Chang, CPB; Rachez, C; Freedman, LP; Miller, WH
    Ligand-inducible interaction of the DRTP/TRAP coactivator complex with retinoid receptors in retinoic acid-sensitive and -resistant acute promyelocytic leukemia cells
    BLOOD
    
    W.L. Shao et al., "Ligand-inducible interaction of the DRTP/TRAP coactivator complex with retinoid receptors in retinoic acid-sensitive and -resistant acute promyelocytic leukemia cells", BLOOD, 96(6), 2000, pp. 2233-2239
86. Grimwade, D; Biondi, A; Mozziconacci, MJ; Hagemeijer, A; Berger, R; Neat, M; Howe, K; Dastugue, N; Jansen, J; Radford-Weiss, I; Lo Coco, F; Lessard, M; Hernandez, JM; Delabesse, E; Head, D; Liso, V; Sainty, D; Flandrin, G; Solomon, E; Birg, F; Lafage-Pochitaloff, M
    Characterization of acute promyelocytic leukemia cases lacking the classict(15;17): results of the European Working Party
    BLOOD
    
    D. Grimwade et al., "Characterization of acute promyelocytic leukemia cases lacking the classict(15;17): results of the European Working Party", BLOOD, 96(4), 2000, pp. 1297-1308
87. Grignani, F; Valtieri, M; Gabbianelli, M; Gelmetti, V; Botta, R; Luchetti, L; Masella, B; Morsilli, O; Pelosi, E; Samoggia, P; Pelicci, PG; Peschle, C
    PML/RAR alpha fusion protein expression in normal human hematopoietic progenitors dictates myeloid commitment and the promyelocytic phenotype
    BLOOD
    
    F. Grignani et al., "PML/RAR alpha fusion protein expression in normal human hematopoietic progenitors dictates myeloid commitment and the promyelocytic phenotype", BLOOD, 96(4), 2000, pp. 1531-1537
88. Wang, H; Zheng, X; Behm, FG; Ratnam, M
    Differentiation-independent retinoid induction of folate receptor type beta, a potential tumor target in myeloid leukemia
    BLOOD
    
    H. Wang et al., "Differentiation-independent retinoid induction of folate receptor type beta, a potential tumor target in myeloid leukemia", BLOOD, 96(10), 2000, pp. 3529-3536
89. Ponzanelli, I; Gianni, M; Giavazzi, R; Garofalo, A; Nicoletti, I; Reichert, U; Erba, E; Rambaldi, A; Terao, M; Garattini, E
    Isolation and characterization of an acute promyelocytic leukemia cell line selectively resistant to the novel antileukemic and apoptogenic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid
    BLOOD
    
    I. Ponzanelli et al., "Isolation and characterization of an acute promyelocytic leukemia cell line selectively resistant to the novel antileukemic and apoptogenic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid", BLOOD, 95(8), 2000, pp. 2672-2682
90. Ruiz-Arguelles, GJ; Ruiz-Delgado, GJ; Reyes-Nunez, V
    PML/RAR alpha(+) hypergranular acute promyelocytic leukemia (M3) developing into an M3 acute myelocytic leukemia without PML/RAR alpha
    ACTA HAEMATOLOGICA
    
    G.J. Ruiz-Arguelles et al., "PML/RAR alpha(+) hypergranular acute promyelocytic leukemia (M3) developing into an M3 acute myelocytic leukemia without PML/RAR alpha", ACT HAEMAT, 104(2-3), 2000, pp. 124-127
91. Kizaki, M; Fukuchi, Y; Ikeda, Y
    A novel retinoic acid-resistant acute promyelocytic leukemia model in vitro and in vivo (review)
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    
    M. Kizaki et al., "A novel retinoic acid-resistant acute promyelocytic leukemia model in vitro and in vivo (review)", INT J MOL M, 4(4), 1999, pp. 359-364
92. Rennert, H; Golde, T; Wilson, RB; Spitalnik, SL; Van Deerlin, VMD; Leonard, DGB
    A novel, non-nested reverse-transcriptase polymerase chain reaction (RT-PCR) test for the detection of the t(15;17) translocation: A comparative study of RT-PCR cytogenetics, and fluorescence in situ hybridization
    MOLECULAR DIAGNOSIS
    
    H. Rennert et al., "A novel, non-nested reverse-transcriptase polymerase chain reaction (RT-PCR) test for the detection of the t(15;17) translocation: A comparative study of RT-PCR cytogenetics, and fluorescence in situ hybridization", MOL DIAGN, 4(3), 1999, pp. 195-209
93. Evans, GD; Grimwade, DJ
    Extramedullary disease in acute promyelocytic leukemia
    LEUKEMIA & LYMPHOMA
    
    G.D. Evans e D.J. Grimwade, "Extramedullary disease in acute promyelocytic leukemia", LEUK LYMPH, 33(3-4), 1999, pp. 219-229
94. Varella-Garcia, M; Brizard, F; Roche, J; Flandrin, G; Drabkin, H; Brizard, A
    Aml1/ETO and Pml/RARA rearrangements in a case of AML-M2 acute myeloblastic leukemia with t(15;17)
    LEUKEMIA & LYMPHOMA
    
    M. Varella-Garcia et al., "Aml1/ETO and Pml/RARA rearrangements in a case of AML-M2 acute myeloblastic leukemia with t(15;17)", LEUK LYMPH, 33(3-4), 1999, pp. 403-406
95. O'Connor, SJM; Evans, PAS; Morgan, GJ
    Diagnostic approaches to acute promyelocytic leukaemia
    LEUKEMIA & LYMPHOMA
    
    S.J.M. O'Connor et al., "Diagnostic approaches to acute promyelocytic leukaemia", LEUK LYMPH, 33(1-2), 1999, pp. 53
96. Tamura, S; Takemoto, Y; Takami, S; Kinoshita, M; Kumano, Y; Aono, H; Mori, M; Kakishita, E
    Efficacy of all-trans retinoic acid for molecular relapse of acute promyelocytic leukemia during remission
    ONCOLOGY REPORTS
    
    S. Tamura et al., "Efficacy of all-trans retinoic acid for molecular relapse of acute promyelocytic leukemia during remission", ONCOL REP, 6(3), 1999, pp. 683-685
97. Buchner, G; Montini, E; Andolfi, G; Quaderi, N; Cainarca, S; Messali, S; Bassi, MT; Ballabio, A; Meroni, G; Franco, B
    MID2, a homologue of the Opitz syndrome gene MID1: similarities in subcellular localization and differences in expression during development
    HUMAN MOLECULAR GENETICS
    
    G. Buchner et al., "MID2, a homologue of the Opitz syndrome gene MID1: similarities in subcellular localization and differences in expression during development", HUM MOL GEN, 8(8), 1999, pp. 1397-1407
98. Grignani, F; Gelmetti, V; Fanelli, M; Rogaia, D; De Matteis, S; Ferrara, FF; Bonci, D; Grignani, F; Nervi, C; Pelicci, PG
    Formation of PML/RAR alpha high molecular weight nuclear complexes throughthe PML coiled-coil region is essential for the PML/RAR alpha-mediated retinoic acid response
    ONCOGENE
    
    F. Grignani et al., "Formation of PML/RAR alpha high molecular weight nuclear complexes throughthe PML coiled-coil region is essential for the PML/RAR alpha-mediated retinoic acid response", ONCOGENE, 18(46), 1999, pp. 6313-6321
99. Kogan, SC; Bishop, JM
    Acute promyelocytic leukemia: from treatment to genetics and back
    ONCOGENE
    
    S.C. Kogan e J.M. Bishop, "Acute promyelocytic leukemia: from treatment to genetics and back", ONCOGENE, 18(38), 1999, pp. 5261-5267
100. He, LZ; Merghoub, T; Pandolfi, PP
     In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications
     ONCOGENE
     
     L.Z. He et al., "In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications", ONCOGENE, 18(38), 1999, pp. 5278-5292